Catalyz is developing affordable diagnostic and care systems for infectious and chronic diseases. The tests need no technical knowledge or any device to interpret the result, hence making it easy for a lame man in confirming or ruling out certain diseases.
Catalyz is developing innovative yet affordable diagnostic and care systems for infectious and chronic diseases. Said Dr. Biju Jacob, CEO, Catalyz Scientific Technologies “Our tests need no technical knowledge or any device to interpret the result, hence making it easy for a lame man in confirming or ruling out certain diseases.”
Mr. Mervin Alexander, Chairman, Technopark TBI and CEO, Technopark congratulated Dr. Biju Jacob and the entire staff of CEO of Catalyz on this achievement.
Dr. Biju Jacob further added “India being a tropical country is prone to several infections and outbreaks of viral diseases. This calls for an increasing need for speedy and specific diagnosis in confirmation of diseases to control potential epidemics. Our diagnostic systems will address these healthcare issues.” Catalyz has been instrumental in launching first Stem Cell Therapy initiative across Kerala State last year. The team has been successful in establishing a pan India network of Stem Cell Therapy units.
Catalyz is promoted by Dr. Biju Jacob, Jestin V.T and Deepak K.P. The trio is working towards the motto of catalyzing healthcare from their R&D centre housed at Technopark TBI Extension Centre, Garden City College, Bangalore.
Technopark in Thiruvananthapuram was established in the year 1994 and is spread over nearly 300 acres with 4 million sq. ft. of built-up space available currently. Technopark hosts over 150 IT and ITES companies employing over 20,000 IT professionals, including five PCMM level 5 company, 6 CMMI level 5 and four CMM Level 3 and over 20 ISO 9001 certified companies. Technopark offers a unique confluence of advantages – robust and failsafe physical infrastructure, power and data connectivity, highly trained technical manpower, most flexible regulatory framework, highest incentives (up to 180,000 USD) and the best law and order environment in India. All this at effectively one-third the operational cost of other comparable locations in India. Techno Park’s vision is to provide a holistic enabling environment to make knowledge industry intrinsically competitive and world class. Technopark is currently on an expansion mode by adding another 92 acres as Phase III expansion and 450 acres as Technocity – an integrated IT township.
About Catalyz Scientific Technologies
Catalyz is a new generation Healthcare Innovations Company focused on point of care diagnostics and stem cell therapeutics. The company is developing proprietary diagnostics and prognostics platforms for different infectious and chronic diseases. Catalyz has partnered with several groups around the world, which are doing pioneering work in the area of adult stem cell research and therapy and is developing adult stem cell-based therapeutic protocols for a number of incurable diseases. Currently, it offers adult stem cell therapy for several diseases including peripheral artery disease, chronic liver disease, spinal cord injury, osteoarthritis, and muscular dystrophy.